In conclusion, our data show that loss of RAI2 in prostate tumor cells matches our observations in the development of treatment-resistant neuroendocrine traits, in agreement with our molecular data demonstrating that RAI2-induced CtBP polymerization is required for the relief of transcriptional repression. Here, RAI2 is linked to prostate neoplasm.